Actively Recruiting
Long-term Clinical Outcomes After Retinal Artery Occlusion
Led by Chonnam National University Hospital · Updated on 2026-03-19
15000
Participants Needed
1
Research Sites
78 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Retinal artery occlusion (RAO) is a rare but vision-threatening vascular disorder that is commonly caused by embolic events originating from the heart or carotid arteries. Patients with RAO are known to have an increased risk of subsequent cardiovascular and cerebrovascular events, including ischemic stroke and myocardial infarction. However, long-term outcomes and optimal medical treatment strategies for these patients remain insufficiently characterized. The purpose of this nationwide population-based study is to investigate the incidence of long-term cardiovascular and cerebrovascular outcomes in patients diagnosed with retinal artery occlusion using the Korean National Health Insurance Service (NHIS) database. In addition, the study aims to evaluate the impact of various medical therapies, including antiplatelet agents, anticoagulants, and statins, on long-term clinical outcomes.
CONDITIONS
Official Title
Long-term Clinical Outcomes After Retinal Artery Occlusion
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients newly diagnosed with retinal artery occlusion
You will not qualify if you...
- Patients with a prior diagnosis of retinal artery occlusion before the study period.
- Patients diagnosed with giant cell arteritis.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Chonnam National University Hospital
Gwangju, Gwangju, South Korea, 61469
Actively Recruiting
Research Team
S
Seung Hun Lee, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here